Pay in 4 interest-free payments of $7.04 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
This factor is significant for weight loss sustaining, given that after subcutaneous semaglutide (2.4 mg) treatment suspension, studies have shown that there may be a weight regain worsening cardiometabolic parameters (60)
Healthy participants were recruited ( n = 9), under the following criteria: (1) age 20 years old
Key Ingredient & Its Benefits
Noom users on a GLP-1 lose 1.4x more weight than those on medication alone*, and in Nooms largest randomized controlled trial of its digital behavior program, members lost an average of 4.1% of their body weight and kept losing for a full year after the program ended, while a control group gained weight
US$ 27.85
US$ 22.10
US$ 22.17
US$ 20.10
US$ 28.26
